Disease Info Card

Chylomicron Retention Disease

Information about Chylomicron Retention Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Chylomicron Retention Disease

Most recent studies have shown that Chylomicron Retention Disease shares some biological mechanisms with abetalipoproteinemia, acanthocytosis, celiac-disease, chronic-diarrhea, diarrhea, failure-to-thrive, familial-hypobetalipoproteinemia, fatty-liver, glycogen-storage-disease-type-iv, hemorrhage, hereditary-diseases, hypobetalipoproteinemias, hypocholesterolemia, intestinal-diseases, malabsorption-syndrome, malignant-neoplasms, malnutrition, steatorrhea, steatosis, vitamin-e-deficiency.

Among the many pathways, these few ones have gauged particular interests from scientists studying Chylomicron Retention Disease, and have been seen in publications frequently: Bone Maturation, Cholesterol Transport, Chylomicron Assembly, Exocytosis, Extracellular Transport, Fatty Acid Transport, Glucose Homeostasis, Glycosylation, Intestinal Absorption, Intracellular Lipid Transport, Intracellular Transport, Lipid Digestion, Lipid Homeostasis, Lipid Transport, Localization, Pathogenesis, Reverse Cholesterol Transport, Secretion, Translation, Transport

Quite a number of genes have been found to play important roles in Chylomicron Retention Disease, such as APOA1, APOB, ATP6V0A1, CRX, FABP1, IQGAP1, MT1B, MTTP, PCSK9, PNLIP, RFC1, RFC2, RFC4, RPGR, SAR1A, SAR1B. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.